Literature DB >> 27866837

High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling.

Emiel P C van der Vorst1, Kosta Theodorou2, Yongzheng Wu3, Marten A Hoeksema4, Pieter Goossens5, Christina A Bursill6, Taghi Aliyev7, Leonie F A Huitema8, Sander W Tas8, Ine M J Wolfs2, Marijke J E Kuijpers9, Marion J Gijbels10, Casper G Schalkwijk11, Debby P Y Koonen12, Shahla Abdollahi-Roodsaz13, Kimberly McDaniels14, Chih-Chieh Wang14, Michael Leitges15, Toby Lawrence5, Jogchum Plat16, Miranda Van Eck17, Kerry-Anne Rye18, Lhousseine Touqui19, Menno P J de Winther4, Erik A L Biessen20, Marjo M P C Donners21.   

Abstract

Membrane cholesterol modulates a variety of cell signaling pathways and functions. While cholesterol depletion by high-density lipoproteins (HDLs) has potent anti-inflammatory effects in various cell types, its effects on inflammatory responses in macrophages remain elusive. Here we show overt pro-inflammatory effects of HDL-mediated passive cholesterol depletion and lipid raft disruption in murine and human primary macrophages in vitro. These pro-inflammatory effects were confirmed in vivo in peritoneal macrophages from apoA-I transgenic mice, which have elevated HDL levels. In line with these findings, the innate immune responses required for clearance of P. aeruginosa bacterial infection in lung were compromised in mice with low HDL levels. Expression analysis, ChIP-PCR, and combinatorial pharmacological and genetic intervention studies unveiled that both native and reconstituted HDL enhance Toll-like-receptor-induced signaling by activating a PKC-NF-κB/STAT1-IRF1 axis, leading to increased inflammatory cytokine expression. HDL's pro-inflammatory activity supports proper functioning of macrophage immune responses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bacterial infection; high-density lipoproteins; immune response; inflammation; inflammatory signaling; macrophages; passive cholesterol depletion

Mesh:

Substances:

Year:  2016        PMID: 27866837     DOI: 10.1016/j.cmet.2016.10.013

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  29 in total

1.  HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages.

Authors:  Alexander N Orekhov; Tatiana Pushkarsky; Yumiko Oishi; Nikita G Nikiforov; Andrey V Zhelankin; Larisa Dubrovsky; Vsevolod J Makeev; Kathy Foxx; Xueting Jin; Howard S Kruth; Igor A Sobenin; Vasily N Sukhorukov; Emile R Zakiev; Anatol Kontush; Wilfried Le Goff; Michael Bukrinsky
Journal:  Exp Mol Pathol       Date:  2018-08-16       Impact factor: 3.362

2.  Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.

Authors:  Panagiotis Fotakis; Vishal Kothari; David G Thomas; Marit Westerterp; Matthew M Molusky; Elissa Altin; Sandra Abramowicz; Nan Wang; Yi He; Jay W Heinecke; Karin E Bornfeldt; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-03       Impact factor: 8.311

Review 3.  Macrophages in vascular inflammation and atherosclerosis.

Authors:  Clement Cochain; Alma Zernecke
Journal:  Pflugers Arch       Date:  2017-02-06       Impact factor: 3.657

4.  High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.

Authors:  Tatjana Josefs; Kristiaan Wouters; Uwe J F Tietge; Wijtske Annema; Robin P F Dullaart; Tomas Vaisar; Ilja C W Arts; Carla J H van der Kallen; Coen D A Stehouwer; Casper G Schalkwijk; Ira J Goldberg; Edward A Fisher; Marleen M J van Greevenbroek
Journal:  J Clin Lipidol       Date:  2019-10-31       Impact factor: 4.766

Review 5.  APOA1: a Protein with Multiple Therapeutic Functions.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Curr Atheroscler Rep       Date:  2021-02-16       Impact factor: 5.113

Review 6.  HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.

Authors:  Fabrizia Bonacina; Angela Pirillo; Alberico L Catapano; Giuseppe D Norata
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

7.  Response by Fotakis et al to Letter Regarding Article, "Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques".

Authors:  Panagiotis Fotakis; Vishal Kothari; Karin E Bornfeldt; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-22       Impact factor: 8.311

8.  Hispidin inhibits LPS-induced nitric oxide production in BV-2 microglial cells via ROS-dependent MAPK signaling.

Authors:  Mei-Hua Jin; Dong-Qin Chen; Ying-Hua Jin; Ying-Hao Han; Hu-Nan Sun; Taeho Kwon
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

9.  Modification of HDL by reactive aldehydes alters select cardioprotective functions of HDL in macrophages.

Authors:  Rebecca L Schill; Darcy A Knaack; Hayley R Powers; Yiliang Chen; Moua Yang; Daniel J Schill; Roy L Silverstein; Daisy Sahoo
Journal:  FEBS J       Date:  2019-08-14       Impact factor: 5.622

10.  HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.

Authors:  Anand Rohatgi; Marit Westerterp; Arnold von Eckardstein; Alan Remaley; Kerry-Anne Rye
Journal:  Circulation       Date:  2021-06-07       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.